OCRA-funded researcher Anil K. Sood, M.D., lead and senior author, and Sanghoon Lee, Ph.D., first author, both at MD Anderson Cancer Center, along with colleagues, identified potential biomarkers in subgroups of … Continued
It’s hard to believe 2020 is almost over, and what a year it’s been. Despite the challenges wrought by the pandemic, we’re grateful to report that thanks to your support, OCRA grantees made great strides … Continued
We’re probably all ready to say goodbye to 2020, if we have to be honest with ourselves. And yet, we can’t look back and say that the year was entirely bad. With your … Continued
OCRA-funded researchers Dr. Sunila Pradeep and Dr. Pradeep Chaluvally-Raghavan, both at the Medical College of Wisconsin, along with colleagues, summarized recent literature on the function of extracellular vesicles “in regulating … Continued
Could the next ovarian cancer breakthrough be traced back to a Commodore 64 home computer? After all, in some small measure, OCRA grantee Dr. Sohrab Shah is where he is … Continued
An international collaborative of scientists, including Dr. Ronald Chandler at Michigan State University, studied ARID1A mutations, which are specific gene mutations observed in deep ovarian and deep infiltrating endometriosis. The … Continued
We’re full on into fall, and giving thanks for all that we’ve accomplished together, in a year that’s been more than a little challenging. RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS EVENTS WAYS … Continued
We’ve got the perfect gift for everyone on your holiday list, and you never have to step foot in a store. With a suggested donation of $25 or more, you … Continued
Be a voice for the ovarian cancer community. Please note: The deadline for application was December 7, 2020. Sign up for email alerts to stay updated on opportunities to take … Continued
Want to learn what’s new in ovarian cancer research and care for 2020? Start here. This fall, we hosted our virtual Uniting for Hope Ovarian Cancer National Conference, where experts … Continued
The Supreme Court is poised to consider California v. Texas, which will decide the fate of the Affordable Care Act (ACA) — their decision could threaten health coverage for millions … Continued
There is an 80% recurrence rate when it comes to ovarian cancer, so the question of ‘what next?’ takes on a huge importance. This is the question that Sarah Gitto, … Continued
Get email updates about research news, action alerts, and ways to join the fight.
